InvestaX Launches World’s 1st Digital SPACs
10.3.2021 05:29:00 EET | Business Wire | Press release
InvestaX, pioneers and creators of next generation technology driven investment products, announces the launch of the world’s first Digital SPACs, using smart contracts and blockchain technologies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210309006112/en/
(Graphic: Business Wire)
InvestaX is a Singapore-headquartered and licensed platform for Digital Securities Offerings (DSOs) of global private markets deals, including venture, private equity & real estate.
Digital SPACs are going to play an integral role in providing necessary capital to growing companies in new industries and give investors access to unique and leading technology companies creating the infrastructure for the digital era.
InvestaX CEO, Julian Kwan, said, “InvestaX and partners, offer Digital SPACs targeting cryptocurrency infrastructure, blockchain and DLT start-ups, games and e-sports, space, robotics, AI, and other future looking industries that are reshaping the 21st century.”
Soul Capital Founder Billy So has built a successful tech portfolio of startups, many in the cryptocurrency industry, and is lead sponsor of the world’s 1st Digital SPAC.
Atlas One is the North America distribution partner.
Sponsors will accept cash or cryptocurrencies as investment, opening up a greater universe of investors and product offerings than traditional SPACs.
Digital SPACs will bring many similar elements of traditional SPACs, but offer a faster, lower cost, more flexible alternative, importantly bringing much needed capital to earlier stage start-ups in new industries, as well as greater transparency and better terms for investors.
Issuing a Digital SPAC using blockchain provides wider distribution channels for global investors who are prevented from, or prefer not to invest through traditional SPACs listed on USA stock exchanges. Digital SPACs will be distributed globally, not just domestically, opening up new markets and opportunities for sponsors and investors.
InvestaX will open source the smart contract code for the Digital SPAC, to bring greater openness, velocity, interoperability and global distribution. The average size of traditional SPACs in 2020 was approx. $350M USD making it challenging to find acquisition targets as the valuation range required is between $1-3BN USD. The first wave of Digital SPACs will target $10-50M USD, ensuring a much larger pool of potential acquisition targets and less competition for sponsors.
InvestaX provides key infrastructure to digitize real assets so you can use them to buy, sell, trade, borrow or lend instantly, across the world, 24x7.
Sign-up at www.investaX.io
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210309006112/en/
Contact information
Julian Kwan
support@investaX.io
+65 9228 0994
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Experian's New Documentary RECLAIM Shows How Financial Access and Innovation Are Creating Opportunity Around the World5.11.2026 17:00:00 EET | Press release
For years, Almir dreamed of meeting his granddaughter in the United States. But unresolved debt stood in the way. Thousands of miles away in Arizona, Elizabeth faced mounting medical expenses after a health crisis. In London, Rochelle worked to regain control of her finances while caring for family members. Their stories, and others like them, are at the heart of RECLAIM: Stories of Passion and Perseverance, a new documentary from global technology and data company Experian that explores how access to financial tools, technology and support can help people overcome obstacles and pursue new opportunities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105341861/en/ Behind-the-scenes photo from the filming of RECLAIM: Stories of Passion and Perseverance, an Experian documentary. Brody Frye, who received care from The MetroHealth System in Cleveland, Ohio, is featured in the film’s story about healthcare innovation and the p
Saudi Fund for Development Signs Six Development Loan Agreements Worth Over USD 403 Million with Syria5.11.2026 16:32:00 EET | Press release
The Saudi Fund for Development (SFD) has signed six concessional development loan agreements worth more than USD 403 million with the Syrian Arab Republic, marking a significant step in supporting the country’s recovery through the rehabilitation of essential infrastructure, restoration of vital public services and improvement of living conditions for communities affected by years of conflict. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105350224/en/ HRH the Crown Prince and President of the Syrian Arab Republic Al-Sharaa witness signing of agreements (Photo: AETOSWire The agreements, signed under the directives of the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister, reflect the Kingdom’s continued commitment to supporting Syria’s development priorities. The signing ceremony was witnessed by Hi
LPs Expect Private Markets Managers to Level Up in 2027: SS&C Intralinks Survey5.11.2026 16:00:00 EET | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced the publication of the 2027 LP Survey. In association with Reuters Insights, SS&C Intralinks surveyed 400 professionals working in private markets, including 370 limited partners and allocators, to understand how the alternative investments market will change in the next 12 months.* “Alternatives once again delivered in 2026, and LPs are still committing capital, but their expectations of managers continue to rise,” said Ken Bisconti, general manager of SS&C Intralinks. “Technology and data capabilities now rank among the most important criteria for selecting managers, alongside investment strategy. Performance alone is no longer enough. For nearly one-third of allocators, a credible artificial intelligence (AI) strategy is now a prerequisite for allocating capital to a manager.” Key findings from the report include: Alternatives portfolios continue to outperform. 62% of respondents said their portfolios exceeded expectati
Hyperice Unveils Normatec Elite Heat Legs: Integrated Heat Meets Dynamic Air Compression in a New Fully Wireless Design5.11.2026 16:00:00 EET | Press release
Hyperice, a high-performance wellness brand, today announced the launch of Normatec Elite Heat Legs, the newest innovation in the award-winning Normatec line and the first Normatec product to incorporate heat directly into its line of dynamic air compression therapy. As the 2024 launch of Normatec Elite signified a transformative leap forward in recovery technology, Elite Heat demonstrates Hyperice’s relentless commitment to offering athletes and wellness enthusiasts alike the most comprehensive and intuitive recovery experiences in the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105782891/en/ Normatec Elite Heat demonstrates Hyperice’s relentless commitment to offering athletes and wellness enthusiasts alike the most comprehensive and intuitive recovery experiences in the world. “Innovation has always been at the forefront of everything we do,” said Jim Huether, CEO of Hyperice. “Heat and dynamic air compressio
European Commission expands license for Alfasigma’s Jyseleca ® (filgotinib) with approval of new indication, treatment of adults with axial spondylarthritis5.11.2026 16:00:00 EET | Press release
The information contained within this press release is for the purpose of scientific exchange. It is intended for scientific, financial and investor media only. Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Commission (EC) has approved an additional indication to Jyseleca® (filgotinib) 200 mg and 100 mg film-coated tablets, an oral once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. A submission for UK approval has been made to the Medicines and Healthcare products Regulatory Agency (MHRA) and is under review. The European Commission’s approval is based on data that support a favourable benefit-risk profile for filgotinib, including efficacy and safety fin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom